Patents by Inventor Min Fu

Min Fu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Integrated Stress Relief Pattern and Registration Structure
    Publication number: 20070187845
    Abstract: A semiconductor die having an integrated circuit region formed in a substrate comprises at least one die-corner-circuit-forbidden (DCCF) region disposed in the substrate, proximate to the integrated circuit region; and at least one registration feature formed within the at least one DCCF region. The at least one registration feature comprises a structure selected from the group consisting of a laser fuse mark, an alignment mark, and a monitor mark.
    Type: Application
    Filed: April 3, 2007
    Publication date: August 16, 2007
    Applicant: TAIWAN SEMICONDUCTOR MANUFACTURING COMPANY, LTD.
    Inventors: Chung-min Fu, Huang-Sheng Lin, Yu-Chyi Harn, Hsien-Wei Chen
  • Compounds as CRFreceptor antagonists
    Patent number: 7250418
    Abstract: The present invention relates to compounds of Formula I, or a stereoisomer thereof, a pharmaceutically acceptable salt thereof, or a prodrug thereof. The compounds of the inventions are CRF1 receptor antagonists. Compounds of the invention are useful for treating, in a warm-blooded animal, particularly a mammal, and more particularly a human, various disorders that are associated with CRF or CRF1 receptors, or disorders the treatment of which can be effected or facilitated by antagonizing CRF1 receptors.
    Type: Grant
    Filed: May 6, 2004
    Date of Patent: July 31, 2007
    Assignee: Pfizer Inc
    Inventors: Jeffrey W. Corbett, Michael Dalton Ennis, Kristine E. Frank, Jian-Min Fu, Robert Louis Hoffman, Patrick R. Verhoest
  • USB PORT TESTER
    Publication number: 20070136025
    Abstract: A Universal Serial Bus (USB) port tester for testing a USB port of an electronic device includes an interface unit, a current-testing unit, and a voltage-testing unit. The interface unit is used for electrically connecting with the USB port of the electronic device and a USB device. The current-testing unit is connected to the interface unit for testing quality of the USB port of the electronic device in a standard current range. The voltage-testing unit is connected to the interface unit for testing quality of the USB port of the electronic device in a standard voltage range.
    Type: Application
    Filed: September 15, 2006
    Publication date: June 14, 2007
    Applicant: HON HAI PRECISION INDUSTRY CO., LTD.
    Inventors: CHIEN-HUNG LO, Tao-Gen Chen, Xiao Su, Min-Fu Deng
  • Integrated stress relief pattern and registration structure
    Patent number: 7202550
    Abstract: A semiconductor die having an integrated circuit region formed in a substrate comprises at least one die-corner-circuit-forbidden (DCCF) region disposed in the substrate, proximate to the integrated circuit region; and at least one registration feature formed within the at least one DCCF region. The at least one registration feature comprises a structure selected from the group consisting of a laser fuse mark, an alignment mark, and a monitor mark.
    Type: Grant
    Filed: November 8, 2004
    Date of Patent: April 10, 2007
    Assignee: Taiwan Semiconductor Manufacturing Company, Ltd.
    Inventors: Chung-min Fu, Huang-Sheng Lin, Yu-Chyi Harn, Hsien-Wei Chen
  • Pyrazolo[1,5-a]pyridine derivatives and their use as neurotransmitter modulators
    Patent number: 7151109
    Abstract: The present invention relates to novel pyrazolo[1,5-a]pyridine derivatives of general formula I: that bind with high affifnity to CRF1 receptors, including human CRF1 receptors. This invention also relates to methods of using the compounds of the invention to treat a disorder or condition, the treatment of which can be effected or facilitated by antagonizing a CRF receptor, such as CNS disorders or diseases, particularly anxiety disorders, and depression and stress related disorders.
    Type: Grant
    Filed: March 12, 2003
    Date of Patent: December 19, 2006
    Assignee: Pharmacia & Upjohn Company LLC
    Inventor: Jian-Min Fu
  • Alternative methodology for defect simulation and system
    Publication number: 20060230371
    Abstract: A system for defect simulation is provided. A defect layout generator generates a defect layout comprising a given number of spot defects of a given size. A processor first compares the defect layout and a provided circuit layout comprising a plurality of conductive regions. The processor further determines whether the spot defects are located on the conductive regions, and determines whether short-circuits and/or open circuits are caused by the spot defects in the conductive regions.
    Type: Application
    Filed: April 6, 2005
    Publication date: October 12, 2006
    Inventors: Jui-Jung Yan, Chung-Min Fu, Ricky Yang
  • SUBSTITUTED PYRIMIDINE DERIVATIVES
    Publication number: 20060217398
    Abstract: This invention relates to compounds of Formula I, a stereoisomer thereof, a pharmaceutically acceptable salt thereof, a prodrug thereof, or a pharmaceutically acceptable salt of a prodrug thereof. The compounds interact with CRF1 receptors, including human CRF1 receptors. This invention also relates to methods of using the compounds of the invention to treat a disorder or condition, the treatment of which can be effected or facilitated by antagonizing a CRF receptor, such as CNS disorders or diseases, particularly anxiety-related disorders such as anxiety, and mood disorders such as major depression.
    Type: Application
    Filed: June 14, 2006
    Publication date: September 28, 2006
    Inventors: Jeffrey Corbett, Micheal Ennis, Kristine Frank, Jian-Min Fu, Robert Hoffman, Patrick Verhoest
  • Substituted pyrimidine derivatives
    Patent number: 7087617
    Abstract: This invention relates to compounds of Formula I, a stereoisomer thereof, a pharmaceutically acceptable salt thereof, a prodrug thereof, or a pharmaceutically acceptable salt of a prodrug thereof. The compounds interact with CRF1 receptors, including human CRF1 receptors. This invention also relates to methods of using the compounds of the invention to treat a disorder or condition, the treatment of which can be effected or facilitated by antagonizing a CRF receptor, such as CNS disorders or diseases, particularly anxiety-related disorders such as anxiety, and mood disorders such as major depression.
    Type: Grant
    Filed: May 5, 2004
    Date of Patent: August 8, 2006
    Assignee: Pfizer Inc.
    Inventors: Jeffrey W. Corbett, Michael Dalton Ennis, Kristine E. Frank, Jian-Min Fu, Robert Louis Hoffman, Patrick R. Verhoest
  • Pyrrolo[1,2-B]pyridazine compounds and their uses
    Publication number: 20060166998
    Abstract: Disclosed are novel CRF receptor antagonists and their use as treatment of a variety of disorders, including disorders manifesting hypersecretion of CRF or associated with CRF or CRF receptors, such as anxiety, and depression. CRF receptor antagonists of the invention have the structure of formula (I): including stereoisomers or mixture of stereoisomers, pharmaceutically acceptable prodrugs, or pharmaceutically acceptable salts thereof, wherein in formula (I) R is H or Me.
    Type: Application
    Filed: March 22, 2006
    Publication date: July 27, 2006
    Inventor: Jian-min Fu
  • Pyrrolo[1,2-b]pyridazine compounds and their uses
    Patent number: 7074791
    Abstract: Disclosed are novel CRF receptor antagonists and their use as treatment of a variety of disorders, including disorders manifesting hypersecretion of CRF or associated with CRF or CRF receptors, such as anxiety, and depression. CRF receptor antagonists of the invention have the structure of formula (I): including stereoisomers or mixture of stereoisomers, pharmaceutically acceptable prodrugs, or pharmaceutically acceptable salts thereof, wherein in formula (I) R1 and R2 are independently selected from H, Me or OMe.
    Type: Grant
    Filed: October 9, 2003
    Date of Patent: July 11, 2006
    Assignee: Pfizer Inc.
    Inventor: Jian-Min Fu
  • Pyrrolo[1,2b]pyridazine compounds and their uses
    Publication number: 20060148807
    Abstract: Disclosed are novel CRF receptor antagonists and their use as treatment of a variety of disorders, including disorders manifesting hypersecretion of CRF or associated with CRF or CRF receptors, such as anxiety, and depression. CRF receptor antagonists of the invention have the structure of formula (I): including stereoisomers or mixture of stereoisomers, pharmaceutically acceptable prodrugs, or pharmaceutically acceptable salts thereof, wherein in formula (I) R is H or Me.
    Type: Application
    Filed: March 17, 2006
    Publication date: July 6, 2006
    Inventor: Jian-min Fu
  • Pyrrolo[1,2-B]pyridazine compounds and their uses
    Patent number: 7056920
    Abstract: Disclosed are novel CRF receptor antagonists and their use as treatment of a variety of disorders, including disorders manifesting hypersecretion of CRF or associated with CRF or CRF receptors, such as anxiety, and depression. CRF receptor antagonists of the invention have the structure of formula (I): including stereoisomers or mixture of stereoisomers, pharmaceutically acceptable prodrugs, or pharmaceutically acceptable salts thereof, wherein in formula (I) R is H or Me.
    Type: Grant
    Filed: March 12, 2004
    Date of Patent: June 6, 2006
    Assignee: Pfizer Inc
    Inventor: Jian-min Fu
  • Pyrrolo[1,2-b]pyridazine compounds and their uses
    Patent number: 7041671
    Abstract: Disclosed are novel CRF receptor antagonists and their use as treatment of a variety of disorders, including disorders manifesting hypersecretion of CRF or associated with CRF or CRF receptors, such as anxiety, and depression. CRF receptor antagonists of the invention have the structure of formula (I): including stereoisomers or mixture of stereoisomers, pharmaceutically acceptable prodrugs, or pharmaceutically acceptable salts thereof, wherein in formula (I) R is H or Me.
    Type: Grant
    Filed: March 12, 2004
    Date of Patent: May 9, 2006
    Assignee: Pfizer Inc
    Inventor: Jian-min Fu
  • Substituted aryl 1, 4-pyrazine derivatives
    Patent number: 7041672
    Abstract: Substituted aryl pyrazine derivatives of the formula I as defined herein, and their use in treating anxiety disorders, depression and stress related disorders are disclosed.
    Type: Grant
    Filed: May 12, 2004
    Date of Patent: May 9, 2006
    Assignee: Pfizer Inc.
    Inventors: Patrick R. Verhoest, Jeffrey W. Corbett, Michael Dalton Ennis, Kristine E. Frank, Jian-Min Fu, Robert Louis Hoffman
  • Pyrrolo[1,2-B]pyridazine compounds and their uses
    Patent number: 7034023
    Abstract: Disclosed are novel CRF receptor antagonists and their use as treatment of a variety of disorders, including disorders manifesting hypersecretion of CRF or associated with CRF or CRF receptors, such as anxiety, and depression. CRF receptor antagonists of the invention have the structure of formula (I): including stereoisomers or mixture of stereoisomers, pharmaceutically acceptable prodrugs, or pharmaceutically acceptable salts thereof, wherein in formula (I) R is H or Me.
    Type: Grant
    Filed: March 12, 2004
    Date of Patent: April 25, 2006
    Assignee: Pfizer Inc
    Inventor: Jian-min Fu
  • Indoles and indolines having 5-HT activity
    Patent number: 7022694
    Abstract: The present invention provides compounds of Formula (I): wherein R1, R2, R3, R4, R5, R6 and --- have any of the values defined in the specification, as well as pharmaceutical compositions comprising the compounds. The invention also provides therapeutic methods as well as processes and intermediates useful for preparing compounds of Formula (I). The compounds are useful as 5-HT ligands.
    Type: Grant
    Filed: July 11, 2002
    Date of Patent: April 4, 2006
    Assignee: Pharmacia & UpJohn Company
    Inventors: Jian-Min Fu, Jeanette Kay Morris, Arthur Glenn Romero
  • Substituted pyrimidinones and pyrimidinthiones
    Patent number: 7015229
    Abstract: This invention relates to substituted pyrimidinone and pyrimidithione derivatives that bind with high affifnity to CRF1 receptors, including human CRF1 receptors. This invention also relates to methods of using the compounds of the invention to treat a disorder or condition, the treatment of which can be effected or facilitated by antagonizing a CRF receptor, such as CNS disorders or diseases, particularly anxiety disorders, and depression and stress related disorders.
    Type: Grant
    Filed: February 20, 2003
    Date of Patent: March 21, 2006
    Assignee: Pfizer Inc
    Inventors: Jian-Min Fu, Jeffrey W. Corbett, Michael Dalton Ennis, Kristine E. Frank, Robert Louis Hoffman, Patrick R. Verhoest
  • Substituted aryl 1,4-pyrazine derivatives
    Patent number: 6992087
    Abstract: Substituted aryl 1,4-pyrazine derivatives of formula I as defined herein and their use in treating anxiety disorders, depression and stress related disorders are disclosed.
    Type: Grant
    Filed: November 15, 2002
    Date of Patent: January 31, 2006
    Assignee: Pfizer Inc
    Inventors: Patrick R. Verhoest, Robert Louis Hoffman, Jeffrey W. Corbett, Michael Dalton Ennis, Kristine E. Frank, Jian-Min Fu
  • Pyridazine derivatives and their use as therapeutic agents
    Publication number: 20060009459
    Abstract: Methods of treating an SCD-mediated disease or condition in a mammal, preferably a human, are disclosed, wherein the methods comprise administering to a mammal in need thereof a compound of formula (Ia): where x, y, W, V, R2, R3, R4, R5, R6, R6a, R7, R7a, R8, R8a, R9 and R9a are defined herein. Pharmaceutical compositions comprising the compounds of formula (I) are also disclosed.
    Type: Application
    Filed: February 9, 2005
    Publication date: January 12, 2006
    Inventors: Nagasree Chakka, Mikhail Chafeev, Sultan Chowdhury, Jian-Min Fu, Duanjie Hou, Rajender Kamboj, Vishnumurthy Kodumuru, Shifeng Liu, Vandna Raina, Shaoyi Sun, Serguei Sviridov, Michael Winther, Zaihui Zhang, Melwyn Abreo, Mark Holladay, Wenbao Li, Sengen Sun, Chi Tu, Heinz Gschwend
  • Integrated stress relief pattern and registration structure
    Publication number: 20050263855
    Abstract: A semiconductor die having an integrated circuit region formed in a substrate comprises at least one die-corner-circuit-forbidden (DCCF) region disposed in the substrate, proximate to the integrated circuit region; and at least one registration feature formed within the at least one DCCF region. The at least one registration feature comprises a structure selected from the group consisting of a laser fuse mark, an alignment mark, and a monitor mark.
    Type: Application
    Filed: November 8, 2004
    Publication date: December 1, 2005
    Applicant: Taiwan Semiconductor Manufacturing Company, Ltd.
    Inventors: Chung-min Fu, Huang-Sheng Lin, Yu-Chyi Harn, Hsien-Wei Chen